Intuitive Surgical

Intuitive Surgical

Price: 412.02

Company and Business Model

Intuitive Surgical is a leader in robotic-assisted surgical systems, primarily known for its da Vinci Surgical System. The company develops and markets advanced surgical technologies, including instruments and accessories that enhance minimally invasive surgery. Its core revenue sources stem from system sales, instrument and accessory sales, and service agreements. The company operates mainly in the healthcare sector, focusing on improving surgical outcomes and patient recovery times.

Investment Profile

Intuitive Surgical's stock is more aligned with growth investors due to its focus on innovation and expanding market presence in robotic surgery. The absence of dividends and the current volatility suggest a higher risk profile, making it less suitable for conservative investors. The company is positioned for potential long-term growth, appealing to those willing to accept higher risk for future returns.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
8.37 OK
Revenue QoQ — quarter-over-quarter revenue growth
-3.3%
EPS surprise
17.9% better than expected
20d volatility
2.5% stable
FMP / FinFeed data updated: 2026-06-09

Forecast impact

negative
Target Lowered · Goldman Sachs · valid until 2026-06-26 · updated 2026-06-11
Target +35.4% target fill 73.8%
Reaction D5 +6.66% · D10 +2.63% market trust
Impact Potential -4 · Risk +3 up to 30 days or until target is reached
Reco: Sell Potential: 33 Risk: 74 Updated: 2026-06-11 05:21
How recommendation works
Why AI thinks so:
Weak momentum and fundamentals raise significant risk concerns.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-05-24 02:42 Hold Sell Weak momentum and fundamentals suggest caution.
2026-05-16 02:32 Sell Hold Weak fundamentals and negative momentum raise significant concerns.
2026-05-08 14:59 Sell Weak momentum and fundamentals raise significant risk concerns.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-02 12:24 Piper Sandler Update — → 580 397.60999
2026-05-27 11:27 Goldman Sachs Target Lowered 621 → 558 436.64
2026-04-23 10:18 Barclays Target Lowered 712 → 651 483.62
Intel Intuitive Surgical

Акции Intel упали более чем на 6% после слабого прогноза по выручке и прибыли, в то время как акции Intuitive Surgical выросли на 3% благодаря сильным квартальным результатам

В послепродажной торговле акции Intel упали более чем на 6% после того, как компания представила слабые прогнозы по выручке и прибыли на акцию за текущий квартал.